Charles W. Newton
Director · Keros Therapeutics, Inc.
IndividualSelling only2 10b5-1 trades
- 2025
- Aug 20, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles W. Newton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Esther Cho - $124K in KROS purchases and sales in the last 12 months
- Jasbir Seehra - $113K in KROS purchases and sales in the last 12 months
- Lorena Raquel Lerner - $100K in KROS purchases and sales in the last 12 months
- Keith Regnante - $77K in KROS purchases and sales in the last 12 months
- Jean Jacques Bienaime - $76K in KROS purchases and sales in the last 12 months
- Nima Farzan - $28K in KROS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles W. Newton?
Charles W. Newton is a corporate insider, tracked as Director of Keros Therapeutics, Inc. (KROS). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Charles W. Newton submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Charles W. Newton been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($29K) across all tracked filings.
